---
id: research-agents-2026
slug: ai-research-agents-scientific-discovery
slug_en: ai-research-agents-scientific-discovery
slug_de: ki-forschungsagenten-wissenschaftliche-entdeckung
title: "Research Agents: Papers That Run, Labs That Cite, and Enzyme-Hunting Loops"
excerpt: "Scientific agents that turn papers into interactive tools and Claude-class systems used in discovery workflows. How R&D teams adopt them without fake citations."
seoTitle: "AI Research Agents for Science and R&D (2026)"
seoDescription: "Use AI research agents on papers and lab data with citations, tool gates and human review — a practical pattern for EU R&D and industry labs."
publishedAt: "2026-09-21T10:00:00.000Z"
author: Musharraf Aziz
cover: /blog/blog-research-agents-cover.webp
coverAlt: "Research papers unfolding into an agent graph on black"
readingTime: 11
tags:
  - research agents
  - scientific AI
  - RAG
  - lab automation
  - Claude
  - R&D
---

Outside the enterprise CRM bubble, this week’s quieter story is **science**. Papers are being wrapped as **interactive agents**. Discovery loops — including **enzyme-related work attributed to Claude-class agents** in industry coverage — show the same architecture as a support agent: retrieve, propose, **call a tool**, criticise, stop.

The failure mode is worse than a wrong delivery ETA. A fake citation in a grant or a patent file is a career event.

![Ingest, agent, human: the lab and desk loop](/blog/blog-research-agents-diagram.webp)

## What a research agent is allowed to be

- A **reader** that quotes passages with page-level citations ([RAG rules](/en/blog/rag-chatbot-company-knowledge) apply twice as hard).
- A **planner** that proposes the next experiment from *your* protocol library.
- A **wrapper** around simulation or LIMS APIs you already trust.

It is not a co-author that “remembers” a method from training data. If the PDF is not in the corpus, the answer is “not in the library”.

## Interactive papers

Turning a paper into an agent means: chunk figures and tables, bind notebooks or demo APIs, let a reader ask “recompute table 2 with our reagent”. That is product work — version the paper, version the code, show hashes. Do not ship a chatbot that *hallucinates* a plot.

## Lab tools and safety

If the tool can **move a robot arm, a pump, or an order in a chemical catalogue**, treat it like production [multi-agent ops](/en/blog/enterprise-multi-agent-systems-2026): allow-lists, two-person rule, no open-ended buying. Enzyme discovery is exciting; unsupervised procurement is not.

## EU R&D specifics

- Training on unpublished lab notes: purpose limitation and inventor identity.
- Export control on some dual-use tools.
- Works-council issues if agents score researchers.

## Worked example: methods librarian

A medtech team dumps 400 internal protocols. Agent answers “sterilisation cycle for product family B” with a citation to SOP-118 §4. It cannot mark a SOP obsolete. A quality officer does. Hallucinated ISO clauses are caught because every answer must quote.

## FAQ

**Can we use the public web?**
As a browse tool with domain allow-lists, maybe. Never as the only source for a regulated method.

**Claude vs local models?**
Sensitive notebooks: EU VPC or on-prem. Drafting literature reviews: a frontier model with RAG may be enough.

**How is this different from a coding agent?**
The artefact is a **claim with evidence**, not a passing test. Your evaluator is a scientist.

We build the retrieval and tool layer as [AI automation](/en/services/ai-automation) for industry R&D, not as a science lab ourselves. [If you have a corpus and a forbidden-action list](/en/contact), that is enough to start.
